Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]-

Request For Quotation
Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- Suppliers list
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: BOC Sciences  
Tel: 16314854226; +8616314854226
Email: inquiry@bocsci.com
Company Name: Nantong Hi-Future Biotechnology Co., Ltd  
Tel: +86-0513; 18051384581
Email: sales@chemhifuture.com
Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- Basic information
Product Name:Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]-
Synonyms:Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]-;DL5050
CAS:2259710-64-8
MF:C23H15Cl2N3O2
MW:436.29
EINECS:
Product Categories:
Mol File:2259710-64-8.mol
Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- Structure
Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- Chemical Properties
density 1.39±0.1 g/cm3(Predicted)
pka5.07±0.30(Predicted)
Safety Information
MSDS Information
Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- Usage And Synthesis
DescriptionDL5050 is a Selective Agonist for the Human Constitutive Androstane Receptor. DL5050 demonstrated excellent potency and selectivity for hCAR over hPXR. DL5050 preferentially induced the expression of CYP2B6 (target of hCAR) over CYP3A4 (target of hPXR) on both the mRNA and protein levels. The selective hCAR agonist DL5050 represents a valuable tool molecule to further define the biological functions of hCAR, and may also be used as a new lead in the discovery of hCAR agonists for various therapeutic applications.
Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]- Preparation Products And Raw materials
Tag:Imidazo[2,1-b]oxazole-5-carboxaldehyde, 6-(2-naphthalenyl)-, O-[(3,4-dichlorophenyl)methyl]oxime, [C(E)]-(2259710-64-8) Related Product Information